Psychiatry Medical News about Global drug development

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Global drug development in cancer: a cross-sectional study of clinical trial registries
Annals of Oncology, 10/20/09

Seruga B et al. – Drug development in cancer is costly and may be directed toward ‘profitable’ cancers of the more developed regions (MDR) as compared with those of the less developed regions (LDR) of the world. Here, the authors describe drug development in relation to cancer type and geographic location. Lethal cancers that are common in the LDR (e.g. stomach, liver and esophageal cancers) deserve greater emphasis for drug development.

FDA Approves Pennsaid(R) Topical Solution
Covidien, 11/10/09 Relevance Score: 80%

Assessment of global capacity to conduct tuberculosis drug development trials: do we have what it takes
The International Journal of Tuberculosis and Lung Disease, 11/02/09 Relevance Score: 79%

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09 Relevance Score: 78%

The long and winding road leading to the identification of the hepatitis C virus
Journal of Hepatology, 11/05/09 Relevance Score: 78%

Roche scientist recognized for excellence in peptide chemistry
Roche, 10/09/09 Relevance Score: 78%